BioSpace News Archive

New Office to House High-Tech Showroom and Planmeca Digital Academy, Offering Hands-on Training and Education Solutions

NuLids System will significantly improve both the signs and symptoms associated with most dry eye disease in less than 30 days.

Study Demonstrates Improvements in Objective Pelvic Floor Muscle Measures, Patient-Reported Urinary Incontinence Severity and Condition-Specific Quality of Life, with Results Evident after 1 Week of Use

Evox Therapeutics Ltd, a leading exosome therapeutics company, is pleased to announce that the Company has been granted three key patents by the United States Patent and Trademark Office and the European Patent Office.

Eli Lilly and Company announced several leadership changes in the company’s corporate business development, oncology R&D, and managed healthcare services organizations.

Masimo announced that in a study published in the Journal of Clinical Monitoring and Computing, researchers investigated the effects of implementing a hospital-wide fluid and blood administration protocol using two Masimo measurements: noninvasive, continuous hemoglobin and pleth variability index.

CVS Health Corporation announced operating results for the three months ended June 30, 2019.

The Ontario Superior Court of Justice has approved a $5 million settlement of a national class action brought against St. Jude Medical, Inc. and St. Jude Medical Canada, Inc.

ScottCare Cardiovascular Solutions and the EP Heart Cardiovascular Electrophysiology Training Program at The University of Texas Health Science Center at Houston (UTHealth) today announced a collaboration intended to provide an intensive training experience for individuals interested in pursuing a career as Cardiac Implantable Electronic Device Specialists and Technical Specialists.

Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management will present and host investor meetings at the 8th Annual Intellisight Conference in Minneapolis, Minn. on Wednesday, August 14th at 7:30 a.m. Central Time.